معرفی
Lorenzo Caggiano is a Senior Lecturer in the Department of Life Sciences at the University of Bath. His research focuses on the synthesis of natural product analogues and their application in drug design, particularly targeting antiproliferative agents for cancer and cardiovascular therapies. He holds a PhD from the University of Cambridge (2002) and a BSc in Chemistry and Industrial Chemistry from the University of Liverpool (1998).
His contributions align with the UN Sustainable Development Goals (SDGs), though specific goals are not detailed. Caggiano has secured significant funding, including the Engineering and Physical Sciences Research Council (EPSRC) Academic Fellowship (2007–2012) as Principal Investigator and a British Heart Foundation grant (2015–2018) as Co-Investigator. His recent work highlights advancements in Pancratistatin hybrid analogs (2024), synthetic methodologies for natural products (2022–2020), and NADPH oxidase inhibition as a novel antiplatelet drug target (2020–2019).
Research interests emphasize medicinal chemistry, drug design, and biological activity screening of compounds. Projects include collaborative efforts to combat thrombosis and pancreatic cancer. Notable achievements include high-impact publications in journals like FASEB Journal and ChemMedChem, with citations and social media engagement reflecting his work's visibility.
Scientific awards include the EPSRC Academic Fellowship, underscoring his expertise. Advising and grants involve supervision of 9 students (names not listed) and leadership in research projects. Lab/team details are not explicitly provided in the text.
